Literature DB >> 30851178

Prevalence of gluten-related disorders in Asia-Pacific region: a systematic review.

Sara Ashtari1, Mohamad Amin Pourhoseingholi1, Kamran Rostami2, Hamid Asadzadeh Aghdaei1, Mohammad Rostami-Nejad3, Luca Busani4, Mostafa Rezaei Tavirani5, Mohammad Reza Zali1.   

Abstract

BACKGROUND AND AIMS: The epidemiology of gluten-related disorders (GRDs) is still an open field to be explored. We conducted this systematic review based on the current epidemiology knowledge of GRDs, focusing on the changing prevalence of GRDs reported in the Asia-Pacific region.
METHODS: We searched Medline, PubMed, Scopus, Web of Science and Cochrane database with the following MeSH terms and keywords: celiac disease (CD), wheat allergy (WA), non-celiac gluten sensitivity (NCGS), dermatitis herpetiformis (DH) and gluten ataxia (GA) and the prevalence studies published from January 1991 to January 2018. Each article was cross-referenced with "Asia-Pacific region" and countries in this region such as Australia, New Zealand, India, Pakistan, Turkey, Iran and others.
RESULTS: We included 66 studies, which reported the prevalence of GRDs in the Asia-Pacific region. Prevalence of celiac disease was 0.32%-1.41% in healthy children and 0.05%-1.22% in the adult population, while the prevalence in the high risk population was higher (0.6%-11.8%). Previous studies have shown a very low incidence of dermatitis herpetiformis (DH) (<0.001%) and gluten ataxia (GA) in this area. Few studies on NCGS outbreaks have been found in this area due to the lack of specific diagnostic biomarkers. Wheat allergy (WA), although uncommon in most Asian-Pacific countries, is the most common cause of anaphylaxis in this region.
CONCLUSION: The results of this systematic review suggest the need to plan further proper epidemiological studies in order to understand the natural history of GRDs and to assess its burden on health systems.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30851178     DOI: 10.15403/jgld.2014.1121.281.sys

Source DB:  PubMed          Journal:  J Gastrointestin Liver Dis        ISSN: 1841-8724            Impact factor:   2.008


  7 in total

1.  Is duodenal biopsy always necessary for the diagnosis of coeliac disease in adult patients with high anti-tissue transglutaminase (TTG) antibody titres?

Authors:  Junaid Beig; Kamran Rostami; David T S Hayman; Summer Hassan; Stephen Gerred; Ravinder Ogra
Journal:  Frontline Gastroenterol       Date:  2021-06-25

2.  Cerebellar Abnormalities on Proton MR Spectroscopy and Imaging in Patients With Gluten Ataxia: A Pilot Study.

Authors:  Vishwa Rawat; Ritu Tyagi; Inder Singh; Prasenjit Das; Achal Kumar Srivastava; Govind K Makharia; Uma Sharma
Journal:  Front Hum Neurosci       Date:  2022-05-17       Impact factor: 3.473

3.  Do gastroenterologists have medical inertia towards coeliac disease? A UK multicentre secondary care study.

Authors:  Matthew A Taylor; Rebecca J Blanshard; Gregory Naylor; Hugo A Penny; Peter D Mooney; David S Sanders
Journal:  BMJ Open Gastroenterol       Date:  2021-01

Review 4.  Maillard Reaction Induced Changes in Allergenicity of Food.

Authors:  Jingkun Gou; Rui Liang; Houjin Huang; Xiaojuan Ma
Journal:  Foods       Date:  2022-02-12

5.  Celiac Disease in Asia beyond the Middle East and Indian subcontinent: Epidemiological burden and diagnostic barriers.

Authors:  Dimitri Poddighe; Diyora Abdukhakimova
Journal:  World J Gastroenterol       Date:  2021-05-21       Impact factor: 5.742

6.  The effects of IL-8, IL- 6, and IL-1 on the risk of celiac disease: a Bayesian regression analysis.

Authors:  Maryam Nasserinejad; Sadjad Shojaee; Mehdi Ghobakhlou; Elena Lak; Pegah Eslami; Mohamad Amin Pourhoseingholi
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2019

7.  Frequency of Celiac Disease in Patients With Chronic Diarrhea.

Authors:  Muhammad S Panezai; Asad Ullah; Kalyani Ballur; Lauren Gilstrap; Jaffar Khan; Bisma Tareen; Mirwais Kakar; Javeria Khan; Amna Rasheed; Abdul Waheed; Intisar Ghleilib; Joseph White; Frederick D Cason
Journal:  Cureus       Date:  2021-12-17
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.